WHOOP, the human performance company, has entered into a strategic partnership with Mubadala Investment Company aimed at strengthening preventative healthcare, performance science, and health research capabilities in the UAE. The collaboration is anchored by Mubadala’s $75 million investment in WHOOP.
Announced during the Make it in the Emirates Forum 2026, the partnership underscores a shared vision to accelerate healthcare innovation, expand advanced research infrastructure, and support the UAE’s ambition to build a globally competitive, knowledge-driven health ecosystem.
The initiative aligns with the UAE’s broader national agenda to attract global innovation, foster local expertise, and position Abu Dhabi as a regional hub for life sciences, advanced healthcare, and future-focused industries.
The partnership also reflects the continued expansion of Mubadala’s healthcare and life sciences strategy toward proactive, data-enabled healthcare systems. By integrating performance science, biomarker testing, longitudinal research, and localized digital health access, the collaboration aims to strengthen the UAE’s healthcare value chain — spanning diagnostics, genomics, prevention, behavioral optimization, and population health resilience.
As part of the agreement, WHOOP will establish a dedicated UAE office, expand its Advanced Labs offering, introduce full Arabic localization across its digital platform, and launch the WHOOP–Mubadala Health Research Initiative.
The research initiative will collaborate with leading UAE institutions to conduct longitudinal studies focused on cardiovascular health, sleep science, recovery, and behavioral performance. The program is expected to enhance the UAE’s advanced research capabilities while supporting innovation in performance science, longevity, and preventative healthcare.
Additionally, the expansion of WHOOP Advanced Labs in the UAE will make the country the first international market to replicate the company’s full U.S.-based biomarker testing experience, supporting precision diagnostics and scalable preventative health models.
The partnership also highlights the UAE’s growing importance within WHOOP’s global growth strategy. The UAE and wider GCC region continue to emerge as key markets for performance and preventative health technologies, driven by increasing wellness awareness, strong digital adoption, and national investments in healthcare innovation.
Will Ahmed, Founder and CEO of WHOOP, said the company’s relationship with the UAE began in 2017 through its collaboration with Expo 2020 Dubai’s Worker Wellness Program.
“Our partnership with Mubadala reflects a shared ambition to build one of the world’s most advanced ecosystems for preventative health, performance science, and research-led innovation,” Ahmed said.
Ali Eid AlMheiri, Executive Director, Diversified Assets, UAE Investments Platform at Mubadala, emphasized the strategic importance of attracting leading international companies to Abu Dhabi.
“Through our partnership with WHOOP, we are bringing advanced health technology, research capabilities, and international expertise into the local ecosystem. This supports long-term knowledge creation, enables innovation, and helps develop industries that contribute to health resilience, talent development, and economic diversification,” he said.
The announcement at MIITE 2026 further demonstrates how healthcare innovation and industrial development are increasingly converging within the UAE’s economic diversification strategy. Beyond healthcare delivery, the partnership is expected to contribute to research infrastructure development, intellectual capital creation, and the advancement of specialized capabilities that support long-term societal well-being and productivity.
